Jpmorgan Chase & CO Encompass Health Corp Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Encompass Health Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,822,646 shares of EHC stock, worth $182 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,822,646
Previous 1,891,721 3.65%
Holding current value
$182 Million
Previous $183 Million 7.92%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$92.35 - $103.77 $6.38 Million - $7.17 Million
-69,075 Reduced 3.65%
1,822,646 $168 Million
Q3 2024

Dec 26, 2024
SELL
$83.97 - $97.17 $28.8 Million - $33.3 Million
-343,062 Reduced 15.35%
1,891,721 $183 Million
Q3 2024

Nov 08, 2024
SELL
$83.97 - $97.17 $28.8 Million - $33.3 Million
-343,062 Reduced 15.35%
1,891,721 $183 Million
Q2 2024

Dec 26, 2024
BUY
$78.62 - $87.09 $27 Million - $29.9 Million
343,062 Added 18.13%
2,234,783 $192 Million
Q2 2024

Aug 12, 2024
SELL
$78.62 - $87.09 $10.8 Million - $11.9 Million
-136,801 Reduced 5.77%
2,234,783 $192 Million
Q1 2024

Dec 26, 2024
BUY
$66.88 - $82.58 $32.1 Million - $39.6 Million
479,863 Added 25.37%
2,371,584 $196 Million
Q1 2024

May 10, 2024
SELL
$66.88 - $82.58 $31.3 Million - $38.6 Million
-467,425 Reduced 16.46%
2,371,584 $196 Million
Q4 2023

Dec 26, 2024
BUY
$60.63 - $67.55 $57.4 Million - $64 Million
947,288 Added 50.08%
2,839,009 $189 Million
Q4 2023

Feb 12, 2024
SELL
$60.63 - $67.55 $7.9 Million - $8.8 Million
-130,257 Reduced 4.39%
2,839,009 $189 Million
Q3 2023

Nov 14, 2023
SELL
$65.21 - $71.81 $8.25 Million - $9.08 Million
-126,511 Reduced 4.09%
2,969,266 $199 Million
Q2 2023

Aug 11, 2023
SELL
$54.1 - $67.71 $2.62 Million - $3.28 Million
-48,370 Reduced 1.54%
3,095,777 $210 Million
Q1 2023

May 18, 2023
BUY
$51.55 - $63.21 $8.84 Million - $10.8 Million
171,504 Added 5.77%
3,144,147 $170 Million
Q1 2023

May 11, 2023
SELL
$51.55 - $63.21 $1.94 Million - $2.38 Million
-37,619 Reduced 1.25%
2,972,643 $161 Million
Q4 2022

Feb 13, 2023
SELL
$47.0 - $59.82 $6.67 Million - $8.49 Million
-141,977 Reduced 4.5%
3,010,262 $180 Million
Q3 2022

Nov 14, 2022
BUY
$45.23 - $53.86 $5.67 Million - $6.75 Million
125,325 Added 4.14%
3,152,239 $143 Million
Q2 2022

Aug 11, 2022
SELL
$42.94 - $59.09 $4.47 Million - $6.15 Million
-104,091 Reduced 3.32%
3,026,914 $170 Million
Q1 2022

May 11, 2022
BUY
$47.33 - $56.71 $825,009 - $988,512
17,431 Added 0.56%
3,131,005 $223 Million
Q4 2021

Feb 10, 2022
SELL
$45.03 - $58.77 $61,556 - $80,338
-1,367 Reduced 0.04%
3,113,574 $203 Million
Q3 2021

Nov 12, 2021
BUY
$59.25 - $66.95 $185 Million - $209 Million
3,114,941 New
3,114,941 $234 Million

Others Institutions Holding EHC

# of Institutions
582
Shares Held
93M
Call Options Held
134K
Put Options Held
47.4K
View Full List

About Encompass Health Corp

EHC Quotes by TradingView
  • Ticker EHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 99,777,600
  • Market Cap $9.97B
  • Description
  • Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients w...
More about EHC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email